Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS)—A 6-Month Pilot Study of a Single Woman’s Experience Changes

Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS)—A 6-Month Pilot Study of a Single Woman’s Experience Changes

<i>Background and Objectives:</i> Women with androgenic Polycystic Ovary Syndrome (PCOS) have increased endometrial cancer risk that cyclic progesterone will prevent; it may also reverse PCOS’s neuroendocrine origins. This pilot study’s purpose was to document 6-month <i>experience...

Full description

Bibliographic Details
Main Authors: Sonia Shirin, Faye Murray, Azita Goshtasebi, Dharani Kalidasan, Jerilynn C. Prior
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Medicina
Subjects:
androgenic PCOS
cyclic oral micronized progesterone therapy
menstrual cycle diary
fluid retention
breast tenderness
Online Access:https://www.mdpi.com/1648-9144/57/10/1024

Internet

https://www.mdpi.com/1648-9144/57/10/1024

Similar Items